View drug registration information details.
| Items | Registration information |
|---|
| ID | 837 |
|---|
| No | 837 |
|---|
| Brand Name | SPARMAKS |
|---|
| Ingredients | SPARSENTAN 200 MG |
|---|
| Dosage Form | TABLET |
|---|
| Primary Packaging | BOTTLE |
|---|
| Storage | STORE AT THE TEMPERATURE BELOW 15-30.C |
|---|
| Shelf Life | 3 YEARS |
|---|
| Pack Size | BOX OF 30'S |
|---|
| Dispensing Category | Prescription only |
|---|
| ATC Classification | |
|---|
| Pharmaceutical Class | NEPHOPATHY TREATMENT' |
|---|
| Indications | TO REDUCE PROTEINURIA IN ADULTS WITH PRIMARY IMMUNOGLOBULIN A NEPHROPATHY AT RISK OF RAPID DISEASE PROGRESSION |
|---|
| Contraindications | |
|---|
| Side Effects | |
|---|
| Unit Price | |
|---|
| EDL |
No |
|---|
| Description | WHITE, BICONVEX FILM COATED TABLET |
|---|
| Note | |
|---|
| License Owner | FACTORY NO.2 |
|---|
| Manufacturer | FACTORY NO. 2 |
|---|
| Country | LAO PDR |
|---|
| Import Registration No | |
|---|
| Import Registration Date | |
|---|
| Activity | CERTIFICATE RELEASED |
|---|
| Applied Date | |
|---|
| FDD Registration No | 07 L 1144/24 |
|---|
| FDD Registration Date | 2024-07-12 |
|---|
| Expiry Date | 2027-07-11 |
|---|
Back to drug list
|
